The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study
- Supplementary File 1:
PDF-Document (PDF, 1462 KiB)
Jiménez-Sousa, M.Á.; Gómez-Moreno, A.Z.; Pineda-Tenor, D.; Brochado-Kith, O.; Sánchez-Ruano, J.J.; Artaza-Varasa, T.; Gómez-Sanz, A.; Fernández-Rodríguez, A.; Resino, S. The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study. J. Clin. Med. 2018, 7, 473. https://doi.org/10.3390/jcm7120473
Jiménez-Sousa MÁ, Gómez-Moreno AZ, Pineda-Tenor D, Brochado-Kith O, Sánchez-Ruano JJ, Artaza-Varasa T, Gómez-Sanz A, Fernández-Rodríguez A, Resino S. The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study. Journal of Clinical Medicine. 2018; 7(12):473. https://doi.org/10.3390/jcm7120473
Chicago/Turabian StyleJiménez-Sousa, María Á., Ana Z. Gómez-Moreno, Daniel Pineda-Tenor, Oscar Brochado-Kith, Juan J. Sánchez-Ruano, Tomas Artaza-Varasa, Alicia Gómez-Sanz, Amanda Fernández-Rodríguez, and Salvador Resino. 2018. "The Myeloid-Epithelial-Reproductive Tyrosine Kinase (MERTK) rs4374383 Polymorphism Predicts Progression of Liver Fibrosis in Hepatitis C Virus-Infected Patients: A Longitudinal Study" Journal of Clinical Medicine 7, no. 12: 473. https://doi.org/10.3390/jcm7120473